HURA
Price
$1.92
Change
-$0.07 (-3.54%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
133.19M
42 days until earnings call
Intraday BUY SELL Signals
NKTR
Price
$43.61
Change
-$3.38 (-7.19%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
2.06B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HURA vs NKTR

HURA vs NKTR Comparison Chart in %
View a ticker or compare two or three
VS
HURA vs. NKTR commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HURA is a Hold and NKTR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
HURA vs NKTR: Fundamental Ratings
HURA
NKTR
OUTLOOK RATING
1..100
1353
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
4763
P/E GROWTH RATING
1..100
10073
SEASONALITY SCORE
1..100
47n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HURA's Valuation (45) in the null industry is in the same range as NKTR (69) in the Biotechnology industry. This means that HURA’s stock grew similarly to NKTR’s over the last 12 months.

HURA's Profit vs Risk Rating (100) in the null industry is in the same range as NKTR (100) in the Biotechnology industry. This means that HURA’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's SMR Rating (97) in the Biotechnology industry is in the same range as HURA (99) in the null industry. This means that NKTR’s stock grew similarly to HURA’s over the last 12 months.

HURA's Price Growth Rating (47) in the null industry is in the same range as NKTR (63) in the Biotechnology industry. This means that HURA’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's P/E Growth Rating (73) in the Biotechnology industry is in the same range as HURA (100) in the null industry. This means that NKTR’s stock grew similarly to HURA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HURANKTR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
83%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (HURA: $1.98 vs. NKTR: $46.99)
Brand notoriety: HURA: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HURA: 110% vs. NKTR: 616%
Market capitalization -- HURA: $133.19M vs. NKTR: $2.06B
HURA [@Biotechnology] is valued at $133.19M. NKTR’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HURA’s FA Score shows that 0 FA rating(s) are green while NKTR’s FA Score has 0 green FA rating(s).

  • HURA’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, HURA is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HURA’s TA Score shows that 3 TA indicator(s) are bullish while NKTR’s TA Score has 4 bullish TA indicator(s).

  • HURA’s TA Score: 3 bullish, 5 bearish.
  • NKTR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than HURA.

Price Growth

HURA (@Biotechnology) experienced а -5.71% price change this week, while NKTR (@Biotechnology) price change was -20.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

HURA is expected to report earnings on Nov 13, 2026.

NKTR is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
HURA
Daily Signal:
Gain/Loss:
NKTR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LDUR93.97-0.14
-0.15%
PIMCO Enhanced Low Duration Active ETF (LDUR)
RFI10.45-0.04
-0.38%
Cohen and Steers Total Return Realty Fund
OCCI2.25-0.04
-1.75%
OFS Credit Company
HSBH107.66-3.32
-2.99%
HSBC HOLDINGS PLC ADRHEDGED
ONDG2.01-0.11
-5.26%
Leverage Shares 2X Long ONDS Daily ETF (ONDG)

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been loosely correlated with CMND. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HURA jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
-5.71%
CMND - HURA
37%
Loosely correlated
-11.09%
SNTI - HURA
35%
Loosely correlated
+3.91%
CLDX - HURA
30%
Poorly correlated
-0.71%
HIND - HURA
30%
Poorly correlated
-1.04%
NKTR - HURA
29%
Poorly correlated
-22.39%
More